Showing 221 - 240 of 584 results.
The results of oestrogen receptor assay at the time of diagnosis of the primary breast tumour.
The type of evidence that confirms a diagnosis of a malignant tumour.
The completion date of hormone therapy administered during the initial course of treatment for cancer.
The systemic therapy agent or protocol administered during the initial course of treatment for cancer.
The amount of macroscopic tumour outside of the primary site of cancer in a person with cancer.
The reason(s) a person with cancer was not administered treatment for cancer.
Whether a person with a solid tumour has received neoadjuvant therapy.
The total number of regional lymph nodes examined by a pathologist in a person with cancer.
The results of a molecular pathology test for genetic and molecular abnormalities in a person with cancer.
The date on which a person with cancer registers for a clinical trial.
The date on which non-surgical treatment for cancer was started.
The date on which non-surgical treatment for cancer was completed.
A code set representing the reference which describes in detail the methods of staging and the definitions for the classification...
A score given at the time of diagnosis outlining the extent to which a person with cancer's disease affects their...
The region of first recurrence as a distant metastasis in a person with cancer, after a disease-free period.
The date on which a molecular pathology test is performed to determine the characteristics of a person with cancer's medical...
The number of a person's sentinel lymph nodes examined by a pathologist and reported as containing tumour.
The total number of a person's sentinel lymph nodes examined by the pathologist.
N stage is the coding system used to denote the absence or presence of regional lymph node metastases. It classifies...
This records the total number outcome of regional lymph nodes examined by the pathologist.